首页> 外文OA文献 >Spatial Arrangements of Connexin43 in Cancer Related Cells and Re-Arrangements under Treatment Conditions: Investigations on the Nano-Scale by Super-Resolution Localization Light Microscopy
【2h】

Spatial Arrangements of Connexin43 in Cancer Related Cells and Re-Arrangements under Treatment Conditions: Investigations on the Nano-Scale by Super-Resolution Localization Light Microscopy

机译:Connexin43在癌症相关细胞中的空间布置和治疗条件下的重新安排:通过超分离子定位光学显微镜对纳米级的研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cancer studies suggest that the spatial localization of connexin43 (Cx43) could play an important role during tumor genesis and the formation of metastasis. Cx43 has been shown to be upregulated in cancer cells; thereby a shift from Cx43 normal localization in gap junctions in the cell membrane towards a primarily cytoplasmic localization was observed in many studies. So far neither the spatial arrangements of Cx43 in breast cancer cells nor the effects of treatment outcome (ionizing radiation and antibody therapy) on the spatial arrangements of Cx43, have been microscopically studied on the nanoscale. This has brought up the idea to study the micro- and nanoscaled spatial Cx43 arrangements in a model of breast cancer-related cell types, i.e., SkBr3 breast cancer cells, BJ fibroblasts, and primary human internal mammary artery endothelial cells (HIMAECs). The cells were treated with neuregulin1 (NRG1), trastuzumab (Herceptin), or 6MeV-photon irradiation at a dose of 4 Gy. NRG1 stimulates further NRG1 release in the tumor endothelium that may lead to an enhanced tumor protective effect whereas Herceptin, used in antibody treatment, works in an antagonistic fashion to NRG1. After fluorescent labelling with specific antibodies, the molecular positions of Cx43 in the perinuclear cytosol and in the cell periphery at the membrane were determined for the three treatment related applications (NRG1, trastuzumab, 4 Gy irradiation) using confocal laser scanning microscopy (CLSM) and single molecule localization microscopy (SMLM). These techniques enable investigations of Cx43 enrichment and topological arrangements of Cx43 molecules from the micro-scale of a whole cell to the nano-scale of single molecules. In SkBr3 cells with and without radiation treatment high density accumulations were detected which seem to be diluted after NRG1 and trastuzumab treatment although the SMLM distance frequency distributions did not significantly vary. In BJ fibroblasts and HIMAECs differences between periphery and perinuclear cytosol were observed after the different treatment processes. HIMAECs showed significant Cx43 accumulation after NRG1, trastuzumab, and radiation treatment in the perinuclear region whereas in the periphery radiation has less influence as compared to the control. BJ cells were reacting to the treatments by Cx43 accumulations in the perinuclear region but also in the periphery. In conclusion, it was shown that by using CLSM and super-resolution SMLM, treatment effects on the spatial and thus functional arrangements of Cx43 became detectable for investigations of tumor response mechanisms.
机译:癌症研究表明Connexin43(CX43)的空间定位可以在肿瘤起源和转移形成期间发挥重要作用。 CX43已被证明在癌细胞中令人上调;由此,在许多研究中观察到从Celecbrane中的间隙结中的CX43正​​常定位转变为主要的细胞质定位。到目前为止,CX43在乳腺癌细胞中的空间布置也不在CX43的空间布置上的治疗结果(电离辐射和抗体治疗)在纳米级上被显微地研究。这使得研究了在乳腺癌相关细胞类型的模型中研究了微型和纳米级的空间CX43布置,即Skbr3乳腺癌细胞,BJ成纤维细胞和初级人类内部乳腺癌内皮细胞(HIMAEC)。用Neuregulin1(NRG1),曲妥珠单抗(Herceptin)或6mev-Photon辐射以4Gy的剂量处理细胞。 NRG1在肿瘤内皮中刺激进一步的NRG1释放,其可能导致肿瘤保护作用的增强型肿瘤保护作用,而在抗体治疗中使用的令人兴奋剂,以拮抗的方式为NRG1作用。在具有特异性抗体的荧光标记之后,使用共聚焦激光扫描显微镜(CLSM)和膜在膜上的CON43在膜中的CX43中的CX43和膜的细胞周周性测定的分子位置,并使用CLOB和CLSM)测定三种处理相关的应用(NRG1,曲据,4GY辐射)。单分子定位显微镜(SMLM)。这些技术使CX43分子的CX43分子的富集和拓扑布置的研究能够从整个细胞的微观级别到单分子的纳米级。在具有辐射处理的SKBR3细胞中,检测到高密度累积,虽然SMLM距离分布没有显着变化,但似乎似乎在NRG1和曲妥珠单抗处理后稀释。在不同的处理过程后观察到在BJ成纤维细胞和HIMAECS之间观察到周边和治疗细胞溶质的差异。 HIMAECs在NRG1,曲妥珠单抗和辐射处理中显示出显着的CX43积累,而在周围辐射与对照相比,在周边辐射中具有较小的影响。 BJ细胞通过ColclecleCare区域中CX43积累的治疗反应,但也是周边。总之,表明通过使用CLSM和超分辨率SMLM,对肿瘤反应机制的研究可检测到CX43的空间和因此功能布置的治疗效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号